Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience

Published:2016-01-05 Issue:1 Volume:11 Page:e0146075
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kauke Teresa,Klimaschewski Sandra,Schoenermarck Ulf,Fischereder Michael,Dick Andrea,Guba Markus,Stangl Manfred,Werner Jens,Meiser Bruno,Habicht Antje

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Analysis of the renal transplant waiting list: application of a parametric competing risk method;JM Smits;Transplantation,1998

2. Luminex and antibody detection in kidney transplantation;A Picascia;Clin Exp Nephrol,2012

3. Detection and clinical relevance of donor specific HLA antibodies: a matter of debate;DL Roelen;Transpl Int,2012

4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation;PC Lee;Transplant Proc,2009

5. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches;AM Patel;Am J Transplant,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

2. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation;Transplantation;2024-04-12

3. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

4. Immunobiology, Diagnosis, and Treatment of Rejection;Transplantation of the Pancreas;2023

5. Imlifidase therapy: exploring its clinical uses;Expert Opinion on Pharmacotherapy;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3